BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Novartis
Citi
Express Scripts
AstraZeneca
McKinsey
Covington
Chinese Patent Office
Daiichi Sankyo
Harvard Business School

Generated: January 22, 2018

DrugPatentWatch Database Preview

TRIPROLIDINE AND PSEUDOEPHEDRINE Drug Profile

« Back to Dashboard

Which patents cover Triprolidine And Pseudoephedrine, and what generic alternatives are available?

Triprolidine And Pseudoephedrine is a drug marketed by Watson Labs, West Ward, Kv Pharm, and Cenci. and is included in five NDAs.

The generic ingredient in TRIPROLIDINE AND PSEUDOEPHEDRINE is codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride. There are nineteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.
Summary for TRIPROLIDINE AND PSEUDOEPHEDRINE
Drug patent expirations by year for TRIPROLIDINE AND PSEUDOEPHEDRINE

US Patents and Regulatory Information for TRIPROLIDINE AND PSEUDOEPHEDRINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs TRIPROLIDINE AND PSEUDOEPHEDRINE pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088318-002 Jan 13, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Kv Pharm TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET, EXTENDED RELEASE;ORAL 072758-001 Nov 25, 1991 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West Ward TRIPROLIDINE AND PSEUDOEPHEDRINE pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088117-001 Apr 19, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Kv Pharm TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES pseudoephedrine hydrochloride; triprolidine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 071798-001 Mar 16, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cenci TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES W/ CODEINE codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride SYRUP;ORAL 089018-001 Jul 23, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Medtronic
Colorcon
Fish and Richardson
Queensland Health
Boehringer Ingelheim
Novartis
Cipla
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot